Core Viewpoint - Yifeng Pharmacy's stock has experienced fluctuations, with a recent decline of 2.02% and a year-to-date increase of 5.46%, indicating mixed market sentiment towards the company [1][2]. Financial Performance - For the first half of 2025, Yifeng Pharmacy reported a revenue of 11.722 billion yuan, a slight decrease of 0.35% year-on-year, while the net profit attributable to shareholders was 880 million yuan, reflecting a growth of 10.32% [2]. - Cumulatively, since its A-share listing, Yifeng Pharmacy has distributed a total of 2.852 billion yuan in dividends, with 1.946 billion yuan distributed over the past three years [3]. Shareholder Structure - As of June 30, 2025, the number of shareholders increased by 7.70% to 21,600, while the average circulating shares per person decreased by 7.15% to 56,081 shares [2]. - The second-largest circulating shareholder is Hong Kong Central Clearing Limited, holding 237 million shares, which is a decrease of approximately 35.39 million shares from the previous period [3]. Market Activity - On September 22, Yifeng Pharmacy's stock price was 24.71 yuan per share, with a trading volume of 60.51 million yuan and a turnover rate of 0.20% [1]. - The stock has seen a net outflow of 3.6248 million yuan in principal funds, with large orders accounting for 11.09% of purchases and 17.08% of sales [1].
益丰药房跌2.02%,成交额6051.12万元,主力资金净流出362.48万元